The same biological processes that drive aging — such as energy loss — may also contribute to lung diseases like chronic ...

Historically considered a sterile environment, the lung is now recognized to host a diverse microbial population. In healthy ...

One of the most striking claims in the review is that AI-based classification models can meet or exceed the performance of ...

Cardiac sarcoidosis (CS) was a complication in about 10% of pulmonary sarcoidosis (PS) cases, investigators reported in Respiratory Medicine. The retrospective study assessed the prevalence, incidence ...

Considerable variability exists in the clinical presentations of pulmonary arterial hypertension (PAH). Greater understanding of the comorbidities observed in Chinese patients with PAH is urgently ...

First-ever use of Ebenbuild’s Twinhale technology in idiopathic pulmonary fibrosis lung models Trial results published in Nature Communications ...

An Osaka Metropolitan University medical research team aimed to investigate the effects of respiratory muscle dysfunction on clinical outcomes related to chronic obstructive pulmonary disease (COPD).

Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

Learn more about supplements for lung health, including vitamins, minerals, and herbs that support breathing, reduce ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data ...

I took the diet drug Redux in the late 1990s. It was pulled off the market due to correlated heart issues. I saw a ...

Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and pulmonary hypertension were found.